You are here

  • Home
  • Archive
  • Volume 7, Issue 1
  • Correction to: Safety and efficacy of nivolumab in combination with sunitinib or pazopanib in advanced or metastatic renal cell carcinoma: the CheckMate 016 study

Article metrics

Article menu

This article has a correction. Please see:

Download PDFPDF

XML
Correction
Correction to: Safety and efficacy of nivolumab in combination with sunitinib or pazopanib in advanced or metastatic renal cell carcinoma: the CheckMate 016 study

 

Online download statistics by month:

Online download statistics by month: December 2019 to March 2026

AbstractFullPdf
Dec 2019010
Jan 2020040
Feb 20200111
Mar 20203192
Apr 2020330
May 2020992
Jun 202020204
Jul 202011110
Aug 2020884
Sep 202022223
Oct 202021216
Nov 202015156
Dec 202015157
Jan 202112124
Feb 202117172
Mar 202175756
Apr 202170704
May 202167673
Jun 202172725
Jul 2021535310
Aug 202138382
Sep 202138387
Oct 2021393919
Nov 2021434319
Dec 202143434
Jan 202237383
Feb 202232321
Mar 202215153
Apr 2022331
May 2022774
Jun 202214144
Jul 202234363
Aug 202240406
Sep 202237379
Oct 202236367
Nov 202234344
Dec 202237373
Jan 2023414314
Feb 202334351
Mar 202342421
Apr 202334356
May 202333368
Jun 202329290
Jul 202338386
Aug 202335356
Sep 202335350
Oct 202335354
Nov 202332321
Dec 202346474
Jan 202424253
Feb 202428281
Mar 2024404058
Apr 2024353512
May 202434348
Jun 202432327
Jul 202441416
Aug 202433336
Sep 202411118
Oct 202427278
Nov 202437383
Dec 202435357
Jan 2025414113
Feb 202519195
Mar 202532324
Apr 2025323210
May 2025363611
Jun 202541416
Jan 2026110
Mar 2026110
Total20342079395